Vanguard Personalized Indexing Management LLC Has $100,000 Stock Holdings in Quanterix Corporation $QTRX

Vanguard Personalized Indexing Management LLC lifted its stake in Quanterix Corporation (NASDAQ:QTRX) by 40.5% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 15,024 shares of the company’s stock after acquiring an additional 4,330 shares during the quarter. Vanguard Personalized Indexing Management LLC’s holdings in Quanterix were worth $100,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Invenomic Capital Management LP bought a new stake in shares of Quanterix during the 1st quarter worth approximately $5,872,000. Trium Capital LLP acquired a new position in Quanterix during the first quarter worth $3,642,000. Nuveen LLC bought a new stake in Quanterix during the first quarter worth $2,704,000. Topline Capital Management LLC acquired a new stake in Quanterix in the first quarter valued at $2,513,000. Finally, Easterly Investment Partners LLC lifted its stake in Quanterix by 38.8% in the first quarter. Easterly Investment Partners LLC now owns 1,325,620 shares of the company’s stock valued at $8,630,000 after acquiring an additional 370,625 shares during the last quarter. 86.48% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of brokerages have recently issued reports on QTRX. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Quanterix in a report on Saturday. Canaccord Genuity Group reissued a “hold” rating and set a $5.00 price target (down previously from $12.00) on shares of Quanterix in a research report on Monday, August 11th. One analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $11.75.

Quanterix Stock Performance

Shares of QTRX opened at $5.72 on Monday. The firm’s 50-day simple moving average is $5.23 and its 200 day simple moving average is $5.48. The firm has a market cap of $265.81 million, a P/E ratio of -3.14 and a beta of 1.07. Quanterix Corporation has a 52 week low of $4.05 and a 52 week high of $15.67.

Quanterix (NASDAQ:QTRX) last issued its quarterly earnings results on Thursday, August 7th. The company reported ($0.47) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.41) by ($0.06). The company had revenue of $24.48 million during the quarter, compared to the consensus estimate of $29.73 million. Quanterix had a negative net margin of 56.04% and a negative return on equity of 18.41%. Quanterix has set its FY 2025 guidance at EPS. As a group, equities analysts forecast that Quanterix Corporation will post -0.98 earnings per share for the current year.

About Quanterix

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.